Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Gritstone Oncology Inc (NASDAQ:GRTS) Begins Phase 1 Clinical Study Of COVID-19…
Timber Pharmaceuticals Inc (NYSE:TMBR) Receives ODD For TMB-003 From The US…
CASI Pharmaceuticals Inc (NASDAQ:CASI) Reports A Growth Of 265% YoY In…
NovaBay Pharmaceuticals (NYSE:NBY) Reports Revenues Of $1.9 Million In Q4 2020:…
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Positive Interim Results From Phase 2…
Finance
GeoVax Labs (GOVX) surges on positive sentiment
Compass Pathways (CMPS) could lead psychedelic sector
Moderna Inc (NASDAQ:MRNA) Signs Deal With Baxter International Inc (NYSE:BAX) For…
Bitcoin Stocks for the Win (SQ, RIOT, ISWH, HVBTF)
The Contrarian Opportunity in Sports Stocks (CHDN, DKNG, BTDG, DKS)
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Gritstone Oncology Inc (NASDAQ:GRTS) Begins Phase 1 Clinical Study Of COVID-19 Vaccine By Dosing The First Person
Matt Wade
-
April 16, 2021
Timber Pharmaceuticals Inc (NYSE:TMBR) Receives ODD For TMB-003 From The US FDA To Cure Systemic Sclerosis: Posts Revenues Of $0.5 Million In 2020
CASI Pharmaceuticals Inc (NASDAQ:CASI) Reports A Growth Of 265% YoY In 2020
NovaBay Pharmaceuticals (NYSE:NBY) Reports Revenues Of $1.9 Million In Q4 2020: Targets Beauty Market In 2021 With CelleRx And Avenova
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Positive Interim Results From Phase 2 Clinical Trial Of Endoxifen In Q4 2020: FDA Permits Expanded Access Of Endoxifen...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Will Commence Phase 2 Clinical Trial...
Kate Hudson
-
April 9, 2021
0
CTI BioPharma Corp (NASDAQ:CTIC) Submits NDA For Its Pacritinib To Treat...
Kate Hudson
-
April 8, 2021
0
Onconova Therapeutics Inc (NASDAQ:ONTX) Inducts Three Patients In The Phase 1...
Gavins Felicity
-
April 7, 2021
0
CEO And President Of AzurRx BioPharma Inc (NASDAQ:AZRX) Discuss Plans To...
Kate Hudson
-
April 6, 2021
0
Jaguar Health Inc (NASDAQ:JAGX) Reports An Impressive Growth Of 147.9% In...
Gavins Felicity
-
April 5, 2021
0
Oragenics, Inc (NYSE:OGEN) Inks A Pact With Biodextris Inc To...
Gavins Felicity
-
April 2, 2021
0
Humanigen Inc. (NASDAQ:HGEN) Announce Encouraging Phase 3 Lenzilumab Study Results...
Kate Hudson
-
April 1, 2021
0
GlaxoSmithKline plc (NYSE:GSK) And Vir Biotechnology Inc (NASDAQ:VIR) Expects To Seek...
Ward Sport
-
March 31, 2021
0
BARDA Awards A Cost Share Contract Of $86.8 Million To ContraFect...
Matt Wade
-
March 30, 2021
0
Caladrius Biosciences Inc (NASDAQ:CLBS) Receives Orphan Drug Designation For Its CD34+...
Kate Hudson
-
March 29, 2021
0
1
2
3
...
84
Page 1 of 84
.td-post-views{ display: none !important; }
